Utah Colorado Biotech Networks
Advertise With Biotech Networks
  • Home
  • About
  • News
    • All News
    • UCBN Trending News
  • Jobs
    • All Jobs
    • Submit a Job
  • Advertise
  • BN Connect
    • BN Connect
    • About Biotech Networks Connect
  • Subscribe
  • Contact
News Ticker
  • [ August 21, 2026 ] Part-time Open Rank Research Services Laboratory Services Professional (Entry – Intermediate) (0.5 FTE) – Aurora, CO Jobs
  • [ August 20, 2026 ] Oncology Account Executive – Salt Lake City, UT Jobs
  • [ August 20, 2026 ] Bucked Up® Launches Hunt: Orange Cream, a Limited-Edition Flavor Built to Fuel Your Hunt News
  • [ August 20, 2026 ] New NCCI data analysis confirms Pinnacol Assurance has fastest, most accurate claims handling in Colorado News
  • [ August 20, 2026 ] Engineer 2 – Human Factors – Lakewood, CO Jobs
HomeNewsStudy Shows Commonly used Diabetes Drug Reduces Risk of Long COVID

Study Shows Commonly used Diabetes Drug Reduces Risk of Long COVID

June 9, 2023 UCBN News Comments Off on Study Shows Commonly used Diabetes Drug Reduces Risk of Long COVID
Study Shows Commonly used Diabetes Drug Reduces Risk of Long COVID

A new study published in The Lancet Infectious Diseases this week has found that metformin, a drug commonly used to treat diabetes, reduces the risk of long COVID.


Click here to view original post

  • colorado
  • CONews
Previous

Plexus Worldwide® Contributes 22,500 Meals to Salt Lake City Through Volunteer Initiative

Next

Neurology Account Manager – Jazz Pharmaceuticals – Denver, CO

Related Articles

No Picture
News

Sierra Space Taps Global Authority on Expandable Space Station Technology for Key Leadership Role

May 21, 2024 UCBN News, Syndication Comments Off on Sierra Space Taps Global Authority on Expandable Space Station Technology for Key Leadership Role

LOUISVILLE, Colo.–(BUSINESS WIRE)–Sierra Space, a leading commercial space-tech company and next generation defense-tech prime building a platform in space to benefit life on Earth, announced today the promotion of Shawn Buckley to Vice President of […]

No Picture
News

Rebalance Health Launches Groundbreaking Products with Proven Clinical Efficacy in Relieving Hot Flashes, Anxiety, and Boosting Testosterone

May 9, 2023 UCBN News Comments Off on Rebalance Health Launches Groundbreaking Products with Proven Clinical Efficacy in Relieving Hot Flashes, Anxiety, and Boosting Testosterone

BOULDER, Colo., May 9, 2023 /PRNewswire/ — Rebalance Health, Inc. (www.rebalancehealth.com), the health and wellness innovators that specialize in optimizing human wellness through cortisol management, have launched three new “Superceutical™” systems, high-potency natural supplements… Click […]

No Picture
News

Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

May 23, 2022 UCBN News Comments Off on Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced today the Seattle Children’s activation of the Phase 1 ENLIGHTen clinical trial in […]

Advertise With Biotech Networks

Copyright © 2026 Biotech Networks

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox